Mkts

Revolution Medicines, Inc.

NASDAQ: RVMD
$180.69-12.37 (-6.41%)
As of Nov 11, 3:09 PM ET

Key statistics

Day range
180.44193.35
52-week range
58.91224.31
Today
Open192.69
Previous close180.69
Volume1.57M
Valuation
Market cap41.44B
P/E ratio—
EPS (TTM)-3.77
Income & risk
Dividend / yield—
Beta1.49
Avg volume2.02M
Discussion

RVMD News

Stories mentioning RVMD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.000.00
Cost of Goods Sold
Gross Profit0.000.000.000.00
Operating Expenses
Research & Development343,970294,943262,506224,134205,749187,520151,752134,932
Sales General & Admin
Total Operating Expenses445,222361,626315,269264,714240,760216,310175,712156,643
Operating Income (Loss)(445,222)(361,626)(315,269)(264,714)(240,760)(216,310)(175,712)(156,643)
Interest Income19,50821,29222,08322,40424,91521,22520,41121,487
Interest Expense
Other Expense117.000.00(10.00)282.0016.00
Pretax Income(453,816)(364,892)(305,206)(247,787)(213,416)(195,322)(156,288)(133,233)
Tax Provision(753.00)0.000.00
Net Income (Loss)(453,816)(364,892)(305,206)(247,787)(213,416)(194,569)(156,288)(133,233)
Earnings Per Share (Basic)(2.29)(1.92)(1.61)(1.31)(1.13)(1.16)(0.94)(0.81)
Earnings Per Share (Diluted)(2.29)(1.92)(1.61)(1.31)(1.13)(1.16)(0.94)(0.81)
Weighted Average Shares Outstanding (Basic)198,098190,129189,232188,583188,146167,738166,844165,142
Weighted Average Shares Outstanding (Diluted)198,098190,129189,232188,583188,146167,738166,844165,142

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About RVMD

Revolution Medicines, Inc. (NASDAQ: RVMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol RVMD. It last traded at $180.69 (Nov 11, 2026, 3:09 PM ET), down 6.4% on the day. That gives Revolution Medicines a market capitalisation of $41.4B.

Over the past 52 weeks RVMD has traded between $58.91 and $224.31.

For the quarter ended Mar 31, 2026 it reported a net loss of $453.8M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$453.8M
Dec 31, 2025—-$364.9M
Sep 30, 2025—-$305.2M
Jun 30, 2025—-$247.8M

From Revolution Medicines’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…